1 Min Read
Aug 21 (Reuters) - Lupin Ltd
* Says receives EIR from U.S. FDA for Aurangabad, April 2017 inspection
* Says EIR closes all outstanding US FDA inspections at Lupin’s Aurangabad facility Source text - bit.ly/2wpy0hS Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.